Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

导出 LinkOut

翻译打印收藏纠错

作者： Mélanie,Lambert ^[1] ; Samy,Jambon ^[2] ; Mohamed A,Bouhlel ^[1] ; Sabine,Depauw ^[1] ; Julie,Vrevin ^[1] ; Samuel,Blanck ^[1] ; Guillemette,Marot ^[3] ; Martin,Figeac ^[4] ; Claude,Preudhomme ^[3] ; Bruno,Quesnel ^[4] ; David W,Boykin ^[5] ; Marie-Hélène,David-Cordonnier ^[6]

作者单位： Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020-U1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies Lille France. ^[1] Université Sorbonne Paris Nord Bobigny France. ^[2] Univ. Lille, CHU Lille, ULR 2694-METRICS Lille France. ^[3] Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, Bilille Lille France. ^[4] Inria, MODAL: Models for Data Analysis and Learning Lille France. ^[5] Plateau de Génomique Fonctionnelle et Structurale, CHU Lille, Univ. Lille, France Lille France. ^[6] Department of Chemistry Georgia State University Atlanta Georgia USA. ^[7]

DOI 10.1002/hem3.77

PMID 38716146

发布时间 2024-06-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

HemaSphere

2024年8卷5期

e77页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

HemaSphere

相似文献

HemaSphere

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

HemaSphere

相似文献

HemaSphere

相关期刊

检索历史清除